Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the month of March 2022 and was filed on April 11, 2022. The report is submitted pursuant to Article 11 of CVM Instruction # 358/2002, detailing transactions involving the company's own securities and derivatives.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. Instead, it reports on treasury share transactions:
- Initial Treasury Balance: 6,307,412 Common Shares.
- Transaction Volume: 16,976,341 Common Shares delivered as restricted shares.
- Transaction Price: R$ 14.68 per share.
- Total Transaction Value: R$ 14,332,685.88.
- Final Treasury Balance: 5,331,071 Common Shares.
Material Changes
The primary material change reported is a reduction in the company's treasury stock of common shares. The balance decreased from 6,307,412 shares to 5,331,071 shares following the delivery of restricted shares directly with the company. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. The document is strictly a regulatory disclosure of share transactions.
Investor Verification Checklist
- Verify the impact of the 16,976,341 restricted share deliveries on total outstanding share count and earnings per share (EPS) in the full Q1 2022 earnings release.
- Confirm the classification of the R$ 14.68 transaction price relative to the market price of Ambev shares during March 2022.
- Review the full Q1 2022 financial statements for revenue, profit, and cash flow data, as this Form 6-K does not contain them.